These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Preventive effect of an E. coli-filtrate (Colibiogen) in polymorphous light eruption.
    Author: Przybilla B, Heppeler M, Ruzicka T.
    Journal: Br J Dermatol; 1989 Aug; 121(2):229-33. PubMed ID: 2673324.
    Abstract:
    During the administration of Colibiogen, a commercially available E. coli-filtrate, there was a significant (P less than 0.01) increase of the test dose of UVA necessary to elicit skin lesions in nine patients with polymorphous light eruptions. Control tests performed in the same manner without the drug indicate that this was due to treatment. Colibiogen appears to be of value in the treatment of polymorphous light eruption (PLE).
    [Abstract] [Full Text] [Related] [New Search]